Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma. - Wikidata - awgldk - TriplyDB

Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.

Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.

http://www.wikidata.org/entity/Q35083852

about

Clinical significance of MET in gastric cancer Molecular targeted therapy for the treatment of gastric cancer Genome-wide analysis of the oxyntic proliferative isthmus zone reveals ASPM as a possible gastric stem/progenitor cell marker over-expressed in cancer.The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.MET in gastric cancer--discarding a 10% cutoff rule Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis.MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?Targeting the hepatocyte growth factor/mesenchymal epithelial transition pathway in gastric cancer: biological rationale and clinical applications.The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells.Pyrazinamide induced hepatic injury in rats through inhibiting the PPARα pathway.

P2860

Q26776190-80DC055B-9864-47CD-B54A-E1622E907788 Q28072433-A2DAB5C4-7299-47DE-A74F-12F649E90C1C Q35692884-1B0BF865-5B20-44F1-82B7-83165E6A0448 Q36228497-C3B86662-93AC-4DDD-9B40-EE2309E816D4 Q36554574-8D89C752-B3A7-4D97-8CF0-D17232B4BA6E Q37342442-2321C476-2434-4B18-AC91-62348AA4FFF3 Q37705824-4FB001CA-53EB-4978-ADC0-3A94377A2930 Q38237693-6872DDE7-B333-40EA-888A-C08979F3723B Q38263575-CE30398A-6CCC-40E8-B689-375A2C6162AE Q52679351-309877A3-15CD-42A6-BB3C-D902AF0FD882 Q53766284-67EB54C6-8197-4EA0-A246-0411C3363EEF

P2860

Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.

http://www.wikidata.org/entity/Q35083852

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Expressions and clinical signi ...... -1 in human gastric carcinoma.

@ast

Expressions and clinical signi ...... -1 in human gastric carcinoma.

@en

type

label

Expressions and clinical signi ...... -1 in human gastric carcinoma.

@ast

Expressions and clinical signi ...... -1 in human gastric carcinoma.

@en

prefLabel

Expressions and clinical signi ...... -1 in human gastric carcinoma.

@ast

Expressions and clinical signi ...... -1 in human gastric carcinoma.

@en

P1433

Q35083852-4F461ECC-B633-4560-ADB4-E40231C7E737

P1476

Q35083852-C9290410-2554-4EE7-A05C-E369D43BDF6D

P2093

Q35083852-106BD900-C3D1-495C-9548-E65E2AFB53B3

Q35083852-2E3279D5-E974-4B5A-B68A-24D5D1F53D05

Q35083852-3CBFFC32-D211-486F-BF64-ADD62A1E77EE

Q35083852-884189F6-E001-4A39-8C4D-1D13BED4CC20

Q35083852-A9ED2115-DF6B-4047-8F13-22186FDB5D28

Q35083852-BD21BBAE-15AD-4EAE-9027-C19DB5AEBC1B

Q35083852-E0EE040B-9960-45F1-878B-47B6D0EB4A43

Q35083852-F9812A68-57A8-4C87-AF54-7D1F3E37A79C

P2860

Q35083852-0D075D23-9B10-4051-A42A-1244131EF1FA

Q35083852-131B05C8-F165-41E8-9321-8AA86CB5D743

Q35083852-185AB87F-89F9-415E-BF2B-708F9BABBB94

Q35083852-313D3EC7-27CE-4971-B164-DFF58A12CD2A

Q35083852-3F58953C-8772-4ECC-A951-AF3DAE18A57F

Q35083852-44AD39EB-FBD5-4D15-9C56-E3393F1DB3E4

Q35083852-5C30D8B7-755C-4012-BF91-8C996CF338ED

Q35083852-68D43D17-2229-4166-9627-3D7BD793D412

Q35083852-81686C7B-3E6B-4145-A595-BCD22AE8E7AE

Q35083852-90FDAE23-0834-49EA-94A4-A5109E32460D

P2888

Q35083852-E9D76CCB-BFAD-4223-A8C3-041297F58B59

P304

Q35083852-1CF6ED49-5305-4D5B-B6A3-C6A418A33526

P31

Q35083852-F99026D7-4514-4774-A2AA-FE15178E701C

P356

Q35083852-BF11DDC1-347C-47DE-8DDA-EB1CA7F864BE

P478

Q35083852-E62DAAEF-6619-4953-AC4C-1EED9D116DEA

P577

Q35083852-8FA7F64F-A07D-4B81-8E3E-DCD1BD5E8F67

P5875

Q35083852-82DF80A1-D914-42BF-A479-837AE6CBCB6D

P6179

Q35083852-D25D6F29-1B93-4C57-A6A1-F0CDC27C059F

P698

Q35083852-0FA835A2-207D-45FA-B088-E701640D0760

P932

Q35083852-566134A7-B0E7-457A-AEF1-53568A08264C

P356

P1433

BMC Research Notes

P1476

Expressions and clinical signi ...... -1 in human gastric carcinoma.

@en

P2093

Bo-jian Jiang

http://www.w3.org/2001/XMLSchema#string

Guang-ye Du

http://www.w3.org/2001/XMLSchema#string

Hong-biao Wu

http://www.w3.org/2001/XMLSchema#string

Ji-wei Yu

http://www.w3.org/2001/XMLSchema#string

Ju-gang Wu

http://www.w3.org/2001/XMLSchema#string

Lin-hai Zheng

http://www.w3.org/2001/XMLSchema#string

Xiao-chun Ni

http://www.w3.org/2001/XMLSchema#string

Xiao-qiang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction of the pRB-family proteins with factors containing paired-like homeodomains

E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer

Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy.

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.

c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases.

Perspectives in the treatment of gastric cancer.

The treatment of advanced gastric cancer: current strategies and future perspectives.

Influencing factors and clinical significance of the metastatic lymph nodes ratio in gastric adenocarcinoma.

The E2F family and the role of E2F1 in apoptosis.

Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.

P2888

P304

6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-0500-7-6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259605785

http://www.w3.org/2001/XMLSchema#string

P6179

1012684213

http://www.w3.org/2001/XMLSchema#string

P698

24393368

http://www.w3.org/2001/XMLSchema#string

P932

3895664

http://www.w3.org/2001/XMLSchema#string